Clinical Trials Logo

Recurrent Gallbladder Carcinoma clinical trials

View clinical trials related to Recurrent Gallbladder Carcinoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01425879 Completed - Clinical trials for Advanced Adult Hepatocellular Carcinoma

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Start date: April 2011
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well MD2206 works in treating patients with advanced refractory biliary cancer that cannot be removed by surgery.

NCT ID: NCT01093222 Completed - Clinical trials for Hilar Cholangiocarcinoma

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Start date: April 2010
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well giving sorafenib tosylate together with erlotinib hydrochloride works in treating patients with locally advanced, unresectable, or metastatic gallbladder cancer or cholangiocarcinoma. Sorafenib tosylate and erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor.